3 completed. 3 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 3 | Completed 3 |
Follow Iris Diseases: new trials by email Literature Review of Iris Diseases trials Research Report on Iris Diseases
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Bromfenac to Reduce Inflammation in Patients With Pseudoexfoliation Syndrome After Cataract Surgery Dexamethasone+Tobramycin eye drop, Bromfenac eye drop - Cataract, Pseudoexfoliation Syndrome | Phase 4 | Completed | Azienda USL Reggio Emilia - IRCCS | 62 | 2013-11-01 | 2025-06-11 |
| Aqueous Flare of a Hydrophobic Acrylic Single-piece Open-loop IOL With Modified Material Surface Properties Polylens EC-HY10-PAL (coated), Polylens EC-Y10-PAL (uncoated) - Cataract, Diabetes | Phase 4 | Completed | Vienna Institute for Research in Ocular Surgery | 40 | 2010-08-01 | 2013-01-11 |
| Assessing Cosopt Switch Patients timolol maleate, dorzolamide/timolol maleate fixed combination - Ocular Hypertension, Open-Angle Glaucoma | Phase 4 | Completed | Pharmaceutical Research Network | 60 | 2005-11-01 | 2008-11-19 |
Exfoliation Syndrome (3) · Cataract (2) · Diabetes Mellitus (1) · Glaucoma, Open-Angle (1) · Ocular Hypertension (1)
Eye Diseases (3) · Uveal Diseases (3) · Lens Diseases (2) · Endocrine System Diseases (1) · Glaucoma (1) · Glucose Metabolism Disorders (1) · Metabolic Diseases (1) · Nutritional and Metabolic Diseases (1)
Timolol (1) · dorzolamide (1)
Azienda USL Reggio Emilia - IRCCS (1) · Pharmaceutical Research Network (1) · Vienna Institute for Research in Ocular Surgery (1)
Austria (1) · Italy (1) · United States (1)
Douglas G. Day, MD (1) · Elizabeth D. Sharpe, MD (1) · J. Charles Henry, MD (1) · Luigi Fontana, MD PhD (1) · Marco Coassin, MD PhD (1) · Mark J. Weiss, MD (1) · Sriram Sonty, MD, FACS (1) · William C. Stewart, MD (1)